Physician profile
Robert Klickovich
NPI 1649204306
$56,732.90
in general payments reported to CMS, 2019-2025
65 companies · $2,268 in 2025
The $2,268 reported for 2025 was more than what 81% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $6,329 · 2021: $6,843 · 2022: $2,332 · 2023: $2,642 · 2024: $2,939 · 2025: $2,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,849.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $31,110.51 | 2019-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $5,595.35 | 2019-2024 | Relistor |
| Boston Scientific Corporation | $3,302.76 | 2019-2025 | Wavewriter Alpha Prime 16, Clinical Trial Product, General - Pain Management |
| Biodelivery Sciences International, INC. | $2,975.04 | 2019-2021 | |
| Mml US, INC. | $1,660.05 | 2021 | |
| Collegium Pharmaceutical, INC. | $1,314.49 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $1,004.70 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Saluda Medical Americas, INC. | $722.65 | 2024-2025 | Evoke |
| Abbvie INC. | $624.86 | 2021-2025 | |
| Pfizer INC. | $545.74 | 2019-2025 | |
| Abbott Laboratories | $478.07 | 2020-2025 | Eterna |
| Lilly USA, LLC | $470.63 | 2019-2024 | Emgality, Reyvow |
| Mdd US Operations, LLC | $374.86 | 2019-2020 | |
| Allergan, INC. | $342.64 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $334.14 | 2019-2024 | Ajovy |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Klickovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.